BCAL Diagnostics Ltd
ASX:BDX

Watchlist Manager
BCAL Diagnostics Ltd Logo
BCAL Diagnostics Ltd
ASX:BDX
Watchlist
Price: 0.1 AUD -2.44% Market Closed
Market Cap: 36.8m AUD

Wall Street
Price Targets

BDX Price Targets Summary
BCAL Diagnostics Ltd

There are no price targets for BDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BCAL Diagnostics Ltd Competitors:
Price Targets
CMPX
Compass Therapeutics Inc.
144% Upside
BAVA
Bavarian Nordic A/S
35% Upside
AUPH
Aurinia Pharmaceuticals Inc
4% Upside
IVVD
Invivyd Inc
166% Upside
2157
Lepu Biopharma Co Ltd
106% Upside
600201
Jinyu Bio-Technology Co Ltd
40% Downside
300896
Imeik Technology Development Co Ltd
38% Upside
2162
KeyMed Biosciences Inc
56% Upside

Revenue
Forecast

Revenue Estimate
BCAL Diagnostics Ltd

For the last 6 years the compound annual growth rate for BCAL Diagnostics Ltd's revenue is 48%. The projected CAGR for the next 1 year is 367%.

48%
Past Growth
367%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
BCAL Diagnostics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
BCAL Diagnostics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BDX's stock price target?
Not Available

BDX doesn't have any price targets made by Wall Street professionals.

What is BCAL Diagnostics Ltd's Revenue forecast?
Projected CAGR
367%

For the last 6 years the compound annual growth rate for BCAL Diagnostics Ltd's revenue is 48%. The projected CAGR for the next 1 year is 367%.

Back to Top